Akèy › Atrit psoryatik › Florid › Clearwater
Etid klinik pou Atrit psoryatik nan Clearwater, FL
5 etid pou Atrit psoryatik ap chèche patisipan nan sit nan ak bò kote Clearwater (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Ap rekriteFaz 3
- Clinical Research of West Florida, Clearwater
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
Ap rekriteFaz 2
- Clinical Research of West Florida 1, Clearwater
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Ap rekriteFaz 3
- Clinical Research of West Florida | Clearwater, FL, Clearwater
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Ap rekriteFaz 3
- Clinical Site, Clearwater
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Ap rekriteFaz 2
- Clinical Research Of West Florida - Phase I Unit /ID# 273198, Clearwater
Etid Atrit psoryatik nan lòt vil
- Houston, TX8 etid
- Charlotte, NC7 etid
- Parma, OH6 etid
- Tampa, FL6 etid
- Philadelphia, PA6 etid
- Altoona, PA6 etid
- Cleveland, OH5 etid
- Plantation, FL5 etid
- New York City, NY5 etid
- Milwaukee, WI5 etid
- San Diego, CA5 etid
- Hialeah, FL4 etid
Lòt etid nan Clearwater
- Maladi kadyovaskilè9 etid
- Lupus8 etid
- Obèsite7 etid
- Kansè nan tete6 etid
- Ensifizyans kadyak6 etid
- Sipwa5 etid
- Kansè Poumon ki pa ti selil5 etid
- Maladi atè koronè5 etid
- Fibrilasyon atriyal5 etid
- Kansè poumon4 etid
- Dyabèt Tip 24 etid
- Kolestewòl4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.